Manufacturing is more complex than identified, likely a two
step process due to evaporating components of the formulation. The final step is combining CBD and due to controlled nature of CBD it was done in both US and AUS. So the final column really should say America/ America, AUS/AUS or America/ AUS depending on how it was done in order to indenture the variability of the prior study results. As per
the last Ann, the 1702 study is exploring another dose ( formulation) which interjects even more complexity.
No news but up 10%, page-31
-
- There are more pages in this discussion • 20 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add BOT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
33.5¢ |
Change
-0.005(1.47%) |
Mkt cap ! $608.8M | |||
| Open | High | Low | Value | Volume |
| 33.5¢ | 34.3¢ | 32.5¢ | $1.200M | 3.588M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 6 | 349093 | 33.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 33.5¢ | 25403 | 5 |
View Market Depth
| Last trade - 16.10pm 11/11/2024 (20 minute delay) ? |
| BOT (ASX) Chart |